Mirae Asset Global ETFs Holdings
CMPX icon

Mirae Asset Global ETFs Holdings’s Compass Therapeutics CMPX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$389K Buy
74,084
+4,508
+6% +$26K ﹤0.01% 2014
2025
Q4 		$374K Buy
69,576
+19,726
+40% +$91.1K ﹤0.01% 2034
2025
Q3 		$176K Sell
49,850
-314
-0.6% -$992 ﹤0.01% 2390
2025
Q2 		$130K Sell
50,164
-10,876
-18% -$22.4K ﹤0.01% 2473
2025
Q1 		$116K Buy
61,040
+2,574
+4% +$6.84K ﹤0.01% 2564
2024
Q4 		$84.8K Buy
58,466
+2,508
+4% +$4.17K ﹤0.01% 2769
2024
Q3 		$103K Buy
55,958
+10,402
+23% +$13K ﹤0.01% 2699
2024
Q2 		$45.6K Buy
+45,556
New +$66.5K ﹤0.01% 2809

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM